Gut microbiota-microRNA interactions in ankylosing spondylitis

Autoimmun Rev. 2021 Jun;20(6):102827. doi: 10.1016/j.autrev.2021.102827. Epub 2021 Apr 20.

Abstract

Ankylosing spondylitis (AS) is a chronic autoimmune inflammatory disability that is part of the rheumatic disease group of spondyloarthropathies. AS commonly influences the joints of the axial skeleton. The contributions to AS pathogenesis of genetic susceptibility (particularly HLA-B27 and ERAP-1) and epigenetic modifications, like non-coding RNAs, as well as environmental factors, have been investigated over the last few years. But the fundamental etiology of AS remains elusive to date. The evidence summarized here indicates that in the immunopathogenesis of AS, microRNAs and the gut microbiome perform critical functions. We discuss significant advances in the immunological mechanisms underlying AS and address potential cross-talk between the gut microbiome and host microRNAs. This critical interaction implicates a co-evolutionary symbiotic link between host immunity and the gut microbiome.

Keywords: Ankylosing spondylitis; Gut microbiota; microRNA.

Publication types

  • Review

MeSH terms

  • Gastrointestinal Microbiome*
  • Genetic Predisposition to Disease
  • HLA-B27 Antigen / genetics
  • Humans
  • MicroRNAs* / genetics
  • Spondylitis, Ankylosing* / genetics

Substances

  • HLA-B27 Antigen
  • MicroRNAs